Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan.
Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1483-1490. doi: 10.1080/14756366.2020.1786820.
A series of 17 compounds () with 2,4,5-trisubstitutedthiazole scaffold having 5-aryl group, 4-carboxylic acid/ester moiety, and 2-amino/amido/ureido functional groups were synthesised, characterised, and evaluated for their carbonic anhydrase (CA)-III inhibitory activities using the size exclusion Hummel-Dreyer method (HDM) of chromatography. Compound with a free amino group at the 2-position, carboxylic acid moiety at the 4-position, and a phenyl ring at the 5-position of the scaffold was found to be the most potent CA-III inhibitor ( = 0.5 μM). The presence of a carboxylic acid group at the 4-position of the scaffold was found to be crucial for the CA-III inhibitory activity. Furthermore, replacement of the free amino group with an amide and urea group resulted in a significant reduction of activity (compounds and , = 174.1 and 186.2 μM, respectively). Thus, compound (2-amino-5-phenylthiazole-4-carboxylic acid) can be considered as the lead molecule for further modification and development of more potent CA-III inhibitors.
一系列具有 2,4,5-三取代噻唑骨架的 17 个化合物(),具有 5-芳基、4-羧酸/酯部分以及 2-氨基/酰胺/脲基官能团,通过排阻层析的 Hummel-Dreyer 方法(HDM)进行了合成、表征和碳酸酐酶(CA)-III 抑制活性评估。在支架的 2 位具有游离氨基、4 位具有羧酸部分和 5 位具有芳基环的化合物 被发现是最有效的 CA-III 抑制剂( = 0.5 μM)。发现支架的 4 位存在羧酸基团对于 CA-III 抑制活性至关重要。此外,将游离氨基替换为酰胺和脲基会导致活性显著降低(化合物 和 , = 174.1 和 186.2 μM,分别)。因此,化合物 (2-氨基-5-苯基噻唑-4-羧酸)可以被认为是进一步修饰和开发更有效的 CA-III 抑制剂的先导分子。